STAT3 and Patent ductus arteriosus: Given the inhibitory effects of STAT3 signaling on NK cells, we found that CAFs in PDA were a major contributor to the inhibition of NK cell function due to IL‐6 secretion, resulting in the loss of innate immune antitumor effects.